Eli Lilly & Co (LLY) - Endocrinology Revenue (DISCONTINUED) (I:ELCLLYER)
Level Chart
Basic Info
|
Eli Lilly & Co (LLY) - Endocrinology Revenue is at a current level of 0.000, unchanged from 0.00 one year ago. This is a change of N/A from one year ago. |
|
Endocrinology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to the field of endocrinology within a specific reporting period. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 0.00 |
| Latest Period | 2022 |
| Last Updated | Jul 27 2023, 09:47 EDT |
| Average Growth Rate | -24.09% |
| Value from 1 Year Ago | 0.00 |
| Change from 1 Year Ago | N/A |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |
Historical Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2016 | 0.00 |
| December 31, 2015 | 7.037B |
| December 31, 2014 | 6.939B |
| December 31, 2013 | 7.304B |
| December 31, 2012 | 6.811B |
Basic Info
|
Eli Lilly & Co (LLY) - Endocrinology Revenue is at a current level of 0.000, unchanged from 0.00 one year ago. This is a change of N/A from one year ago. |
|
Endocrinology Revenue refers to the total revenue generated by Eli Lilly & Co from its products and treatments related to the field of endocrinology within a specific reporting period. |
| Report | FinChat.io |
| Category | Segments & KPIs |
| Region | United States |
| Source | FinChat.io |
|
Data provided via FinChat.io |
Stats
| Last Value | 0.00 |
| Latest Period | 2022 |
| Last Updated | Jul 27 2023, 09:47 EDT |
| Average Growth Rate | -24.09% |
| Value from 1 Year Ago | 0.00 |
| Change from 1 Year Ago | N/A |
| Frequency | Yearly |
| Unit | USD |
| Adjustment | N/A |
Related Securities
Related Indicators
| Eli Lilly & Co (LLY) - Animal Health Revenue (DISCONTINUED) | 0.00 USD |
| Eli Lilly & Co (LLY) - Cardiovascular Revenue (DISCONTINUED) | 0.00 USD |
| Eli Lilly & Co (LLY) - Diabetes Revenue | 19.67B USD |
| Eli Lilly & Co (LLY) - Diabetes Revenue | 5.746B USD |
| Eli Lilly & Co (LLY) - Immunology Revenue | 3.798B USD |
| Eli Lilly & Co (LLY) - Immunology Revenue | 1.104B USD |
| Eli Lilly & Co (LLY) - Neuroscience Revenue | 2.878B USD |
| Eli Lilly & Co (LLY) - Neuroscience Revenue | 362.80M USD |
| Eli Lilly & Co (LLY) - Oncology Revenue | 6.658B USD |